-
Loading metrics
Open Access
Peer-reviewed
Research Article
In a randomized trial, the live attenuated tetravalent dengue vaccine TV003 is well-tolerated and highly immunogenic in subjects with flavivirus exposure prior to vaccination
-
Stephen S. Whitehead ,
¶‡ These authors share first authorship on this work.
Affiliation Laboratory of Infectious Diseases, National Institutes of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America
⨯ -
Anna P. Durbin ,
¶‡ These authors share first authorship on this work.
Affiliation Center for Immunization Research, Johns Hopkins School of Public Health, Baltimore, Maryland; United States of America
⨯ -
Kristen K. Pierce,
Affiliation Vaccine Testing Center, Department of Medicine, University of Vermont Larner College of Medicine, Burlington, Vermont, United States of America
⨯ -
Dan Elwood,
Affiliation Center for Immunization Research, Johns Hopkins School of Public Health, Baltimore, Maryland; United States of America
⨯ -
Benjamin D. McElvany,
Affiliation Vaccine Testing Center, Department of Medicine, University of Vermont Larner College of Medicine, Burlington, Vermont, United States of America
⨯ -
Ellen A. Fraser,
Affiliation Vaccine Testing Center, Department of Medicine, University of Vermont Larner College of Medicine, Burlington, Vermont, United States of America
⨯ -
Marya P. Carmolli,
Affiliation Vaccine Testing Center, Department of Medicine, University of Vermont Larner College of Medicine, Burlington, Vermont, United States of America
⨯ -
Cecilia M. Tibery,
Affiliation Center for Immunization Research, Johns Hopkins School of Public Health, Baltimore, Maryland; United States of America
⨯ -
Noreen A. Hynes,
Affiliation Center for Immunization Research, Johns Hopkins School of Public Health, Baltimore, Maryland; United States of America
⨯ -
Matthew Jo,
Affiliation Center for Immunization Research, Johns Hopkins School of Public Health, Baltimore, Maryland; United States of America
⨯ -
Janece M. Lovchik,
Affiliation Center for Immunization Research, Johns Hopkins School of Public Health, Baltimore, Maryland; United States of America
⨯ -
Catherine J. Larsson,
Affiliation Vaccine Testing Center, Department of Medicine, University of Vermont Larner College of Medicine, Burlington, Vermont, United States of America
⨯ -
Elena A. Doty,
Affiliation Vaccine Testing Center, Department of Medicine, University of Vermont Larner College of Medicine, Burlington, Vermont, United States of America
⨯ -
Dorothy M. Dickson,
Affiliation Vaccine Testing Center, Department of Medicine, University of Vermont Larner College of Medicine, Burlington, Vermont, United States of America
⨯ -
Catherine J. Luke,
Affiliation Laboratory of Infectious Diseases, National Institutes of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America
⨯ -
Kanta Subbarao,
Affiliation Laboratory of Infectious Diseases, National Institutes of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America
⨯ -
Sean A. Diehl ,
* E-mail: sean.diehl@med.uvm.edu (SAD); beth.kirkpatrick@uvm.med.edu (BDK)
Affiliation Vaccine Testing Center, Department of Medicine, University of Vermont Larner College of Medicine, Burlington, Vermont, United States of America
⨯ - [ ... ],
-
Beth D. Kirkpatrick
* E-mail: sean.diehl@med.uvm.edu (SAD); beth.kirkpatrick@uvm.med.edu (BDK)
Affiliation Vaccine Testing Center, Department of Medicine, University of Vermont Larner College of Medicine, Burlington, Vermont, United States of America
⨯ - [ view all ]
- [ view less ]
In a randomized trial, the live attenuated tetravalent dengue vaccine TV003 is well-tolerated and highly immunogenic in subjects with flavivirus exposure prior to vaccination
- Stephen S. Whitehead,
- Anna P. Durbin,
- Kristen K. Pierce,
- Dan Elwood,
- Benjamin D. McElvany,
- Ellen A. Fraser,
- Marya P. Carmolli,
- Cecilia M. Tibery,
- Noreen A. Hynes,
- Matthew Jo
-
- Published: May 8, 2017
- https://doi.org/10.1371/journal.pntd.0005584